A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus α1-antichymotrypsin-prostate-specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia

被引：0
|
作者：
Jung, K
Brux, B
Knäbich, A
Lein, M
Sinha, P
Schnorr, D
Loening, SA
机构：
[1] Humboldt Univ, Univ Hosp Charite, Dept Urol, D-10098 Berlin, Germany
[2] Humboldt Univ, Univ Hosp Charite, Dept Lab Med, D-10098 Berlin, Germany
来源：
CLINICAL CHEMISTRY | 1999年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：422 / 424
页数：3
相关论文
共 50 条
  • [1] Complexed prostate-specific antigen and the "prostate-specific antigen gap"
    Croal, BL
    Mitchell, I
    Dickie, A
    Duff, PA
    Cohen, NP
    Ross, IS
    [J]. CLINICAL CHEMISTRY, 1999, 45 (11) : 2040 - 2040
  • [2] The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer
    Partin, AW
    Carter, HB
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) : 531 - +
  • [3] Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression
    Levitt J.M.
    Slawin K.M.
    [J]. Current Urology Reports, 2007, 8 (4) : 269 - 274
  • [4] Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
    Avci, Sinan
    Onen, Efe
    Caglayan, Volkan
    Kilic, Metin
    Sambel, Murat
    Oner, Sedat
    [J]. ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (01) : 1 - 6
  • [5] Review on the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen
    vanIersel, MP
    Witjes, WPJ
    Thomas, CMG
    Segers, MFG
    Oosterhof, GON
    Debruyne, FMJ
    [J]. PROSTATE, 1996, : 48 - 57
  • [6] Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis
    Lein, M
    Jung, K
    Elgeti, U
    Petras, T
    Stephan, C
    Brux, B
    Sinha, P
    Winkelmann, B
    Schnorr, D
    Loening, SA
    [J]. EUROPEAN UROLOGY, 2001, 39 (01) : 57 - 64
  • [7] Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
    Duvedi, Priya
    Singh, Harjinder
    Bedi, Gurdeep Kaur
    Kaur, Maninder
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (05) : BC01 - BC03
  • [8] MEASUREMENT OF THE PROPORTION OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN IMPROVES DIAGNOSTIC PERFORMANCE OF PROSTATE-SPECIFIC ANTIGEN IN THE DIAGNOSTIC GRAY ZONE OF TOTAL PROSTATE-SPECIFIC ANTIGEN
    LUDERER, AA
    CHEN, YT
    SORIANO, TE
    KRAMP, WJ
    CARLSON, G
    CUNY, C
    SHARP, T
    SMITH, W
    PETTEWAY, J
    BRAWER, MK
    THIEL, R
    [J]. UROLOGY, 1995, 46 (02) : 187 - 194
  • [9] CORRELATION OF PROSTATE-SPECIFIC ANTIGEN AND PROSTATE-SPECIFIC ANTIGEN DENSITY WITH OUTCOME OF PROSTATE BIOPSY
    BARE, R
    HART, L
    MCCULLOUGH, DL
    [J]. UROLOGY, 1994, 43 (02) : 191 - 196
  • [10] Benign prostatic hyperplasia and prostate-specific antigen
    Pejcic, Tomislav
    Acimovic, Miodrag
    Dzamic, Zoran
    Radovanovic, Milan
    Hadzi-Djokic, Jovan
    [J]. VOJNOSANITETSKI PREGLED, 2015, 72 (05) : 447 - 453
12345